ImmuCell Corporation
NASDAQICCC has delivered its sharpest monthly rally in years, climbing 30% to $8.44 over the past month, with an 8% gain just this week. The timing matters: the stock is moving into a May 15 earnings date while the borrow market is loosening and governance is being actively reshaped. The most noteworthy development is corporate rather than technical. ImmuCell filed two new Form 3s on…
Snapshot as of 9 May 2026
ICCC has delivered its sharpest monthly rally in years, climbing 30% to $8.44 over the past month, with an 8% gain just this week. The timing matters: the stock is moving into a May 15 earnings date while the borrow…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ICCC — free to start on ORTEX.
Sign up for free →Open ICCC on ORTEX